XTalks

FEBRUARY 19, 2024

Moderna has been testing an experimental mRNA vaccine aimed at combating the human cytomegalovirus (CMV), which poses significant health risks to newborns and immunocompromised patients. The team used the data and patient samples from a gB/MF59 Phase II trial in adolescent girls as a benchmark to assess the new mRNA-based vaccine.

Vaccination 59

Vaccination Vaccine Trials Clinical Trials 59

XTalks

MAY 10, 2023

In this episode, Ayesha talked about the FDA approval of the world’s first vaccine for respiratory syncytial virus (RSV). The vaccine is approved for adults 60 years of age and older. Read more about the vaccine, including clinical trial results on its efficacy and safety.

Life Science 52

Life Science Vaccination Vaccine FDA Approval 52

XTalks

APRIL 7, 2021

In this episode of the Xtalks Life Science Podcast, Ayesha discusses a report from the Center for Countering Digital Hate (CCDH) and Anti-Vax Watch that shows there are just 12 people behind 65 percent of all online anti-vaccine disinformation. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 59

Life Science Vaccination Vaccine Trials 59

XTalks

MAY 19, 2023

Clinical trials play a vital role in advancing patient treatment and medical care. This article delves into ten trends and statistics in the world of clinical trials for 2023. Increasing Number of Registered Clinical Trials As of May 17, 2023, there are 452,604 registered clinical trials globally on ClinicalTrials.gov.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Clinical Research 97

Pharma in Brief

JUNE 26, 2022

On June 22, 2022, the Canadian Institutes of Health Research ( CIHR ) announced the launch of the Clinical Trials Fund ( CTF ), which will inject funding into Canada’s clinical trials environment. The CTF is part of Canada’s broader Biomanufacturing and Life Sciences Strategy , a $2.2

Clinical Trials 52

Clinical Trials Clinical Trials Trial Funding Trials 52

XTalks

APRIL 6, 2022

In this episode, Ayesha shared insights she obtained from experts at NIH’s National Heart, Lung and Blood Institute (NHLBI) about clinical trial diversity. Read the full articles here: Xtalks Voices: NIH Experts Share Insights on Increasing Clinical Trial Diversity.

Life Science 52

Life Science Clinical Trials Clinical Trials Trials 52

Drug Discovery World

OCTOBER 11, 2023

MinervaX, a Danish biotechnology company developing a novel, prophylactic vaccine against Group B streptococcus (GBS), has announced the completion of €54 million upsized financing. GBS is a leading cause of life-threatening infections in newborns as well as adverse pregnancy outcomes such as preterm delivery and stillbirths.

Vaccination 59

Vaccination Vaccine Clinical Trials Clinical Trials 59

WCG Clinical

APRIL 20, 2023

Published by the Journal for Clinical Studies Volume 15 Issue 1 Mar 30, 2023 The imperative to obtain a diverse body of clinical trial participants has been stressed in public statements for decades; however, parties executing clinical trials have remained insufficiently effective in addressing it.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

XTalks

NOVEMBER 6, 2020

Canadian clinical-stage biotech company Symvivo Corporation has developed an oral COVID-19 vaccine that entered clinical trials this week. The first healthy volunteer was dosed with the vaccine in Australia as part of the bacTRL-Spike COVID-19 Phase I clinical trial. BacTRL Gene Therapy Platform.

Clinical Trials 75

Clinical Trials Clinical Trials Vaccination Vaccine 75

XTalks

DECEMBER 17, 2021

Xtalks is taking a look at some of the major stories and innovations of the year in the life sciences, many of which were driven by new, emerging and improved technologies. The year continued to be dominated by COVID-19, and the second year of the pandemic was all about vaccines. COVID-19: The Pandemic and the Vaccines.

Life Science 98

Life Science Vaccination Vaccine Trials 98

XTalks

MAY 4, 2023

However, there are ongoing clinical trials for celiac disease to investigate potential new treatments. Overall, the state of clinical trials for celiac disease is promising, as researchers are actively working to develop new treatments that could help improve the lives of people with the condition.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Immune Response 98

XTalks

JULY 20, 2022

In this episode, Ayesha discussed the FDA authorization of Novavax’s COVID-19 vaccine, making it the fourth authorized/approved COVID vaccine in the US. It is also the first protein-based COVID-19 vaccine to be authorized in the country. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Vaccination Vaccine Drugs 52

XTalks

DECEMBER 29, 2022

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

XTalks

NOVEMBER 23, 2022

Ayesha also talked about the latest positive Phase III trial data that Pfizer recently shared for its maternal RSV vaccine candidate. Hear more about the vaccine trial data, based on which an independent data monitoring committee has recommended that Pfizer file with the FDA for approval.

Life Science 52

Life Science FDA Approval Vaccination Vaccine 52

XTalks

JANUARY 5, 2021

This year will see the rolling out of much-awaited pandemic-ending COVID-19 vaccines. The pandemic itself will also continue to spur innovations and changes such as greater shifts towards decentralized clinical trials and patient-centric approaches. 2. Decentralized Clinical Trials.

Life Science 98

Life Science Clinical Trials Clinical Trials Trials 98

pharmaphorum

DECEMBER 22, 2022

Construction will start early next year of a new manufacturing centre in the UK with the capacity to produce 250 million vaccine doses per year, the centrepiece of a 10-year alliance between the government and US biotech Moderna. The first vaccines are due to be produced at the new facility in 2025.

Vaccination 122

Vaccination Vaccine Life Science Manufacturing 122

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. The same principles are increasingly being applied to clinical trials to improve diversity, mitigate bias, and reinforce inclusion in clinical trials.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

XTalks

MAY 28, 2024

In a move signaling a major shift in influenza prevention strategies, CSL Seqirus, a global leader in flu vaccines, has transitioned from quadrivalent to trivalent formulations for the upcoming 2024/25 flu season in the US.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

XTalks

MAY 20, 2021

Today is Clinical Trials Day 2021 — a day for recognizing the importance of clinical research in protecting and improving global health. Amid the alarmist headlines posted by other media outlets, Xtalks has remained balanced in its reporting of COVID-19 clinical trial results and safety data.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Vaccination 105

The Pharma Data

MARCH 20, 2021

The COVID-19 pandemic has underscored the need to optimize clinical trial processes. While the public-private initiative Operation Warp Speed has won public attention for its ability to speed vaccine development and distribution, “it has also focused new attention on common bottlenecks in the clinical trial process,” said C.J.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

XTalks

MAY 6, 2021

But rather than looking at these circumstances as barriers, job seekers should keep an open mind and rest assured that there are a wide range of jobs in the life sciences fields, like the pharmaceutical and medical device industries. Clinical research. Research and development (R&D). Formulation and development.

Life Science 91

Life Science Manufacturing Engineer Vaccination 91

pharmaphorum

JUNE 11, 2021

The development of vaccines for COVID-19 has been a masterclass in effective collaboration and applied digitisation in healthcare. Abel Archundia discusses how COVID-19 has highlighted the importance of securing clinical trials against cyber threats. billion doses were administered to people worldwide.

Clinical Trials 111

Clinical Trials Clinical Trials Trials Compliance 111

pharmaphorum

JULY 7, 2021

The ABPI’ s chief executive Dr Richard Torbett outlines a new ‘vision’ and 10-year strategy for UK life sciences, launched by the government today. After an extraordinary year of science versus disease, the UK has cemented itself at the forefront of the global response to COVID-19. This can also benefit patients and the NHS.

Life Science 59

Life Science Manufacturing Genome Genomics 59

XTalks

SEPTEMBER 21, 2023

announced that the first participant has been dosed in a new Phase I trial for an innovative HIV vaccine candidate, VIR-1388. The trial’s primary objective is to assess the safety of VIR-1388 and its capacity to stimulate a specific immune response against HIV in study participants. Vir Biotechnology, Inc.,

Vaccination 59

Vaccination Vaccine Trials Clinical Trials 59

XTalks

JULY 19, 2022

The US Food and Drug Administration (FDA) has given emergency use authorization (EUA) to Novavax’s COVID-19 vaccine, making it the fourth authorized vaccine in the US against COVID-19. The vaccine is branded as Nuvaxovid outside the US with approvals/authorizations in Canada, the EU, UK, Australia and South Korea.

Vaccination 94

Vaccination Vaccine Protein Clinical Trials 94

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Involving patients in discussions. There’s also that risk of a perceived coercion or influence.

Clinical Trials 91

Clinical Trials Clinical Trials Trials Clinical Research 91

pharmaphorum

MARCH 4, 2021

UK chancellor Rishi Sunak has announced a budget loaded with initiatives designed to kick-start the UK’s economy as it recovers from the coronavirus pandemic, with vaccine development, pharma and life sciences playing a key role. This will provide a major incentive to modernise, digitise and grow companies across the country.

Vaccination 105

Vaccination Vaccine Development Life Science 105

Crucial Data Soutions

APRIL 27, 2020

The COVID-19 pandemic that struck the globe this year has drastically disrupted the state of affairs in the life sciences industry. Traditional methods of clinical data collection and trial management encountered change in mid-March as the FDA released guidance on conducting trials during the pandemic.

Clinical Trials 85

Clinical Trials Clinical Trials Trials Life Science 85

Drug Discovery World

MARCH 30, 2023

Likang Life Sciences has been granted implied approval by China’s National Medical Products Administration (NMPA) for the clinical trial of its innovative personalised neoantigen-targeted vaccine LK101 Injection for advanced solid tumours.

Regulation 52

Regulation Vaccination Vaccine Trials 52

The Pharma Data

MARCH 15, 2022

Investment will accelerate the overall Sarclisa ® development program Sanofi will continue to fully manage the clinical program and retain full rights and control of Sarclisa ® (isatuximab). For more information on Sarclisa ® clinical trials, please visit www.clinicaltrials.gov. About Blackstone Life Sciences.

Life Science 52

Life Science Antibody Clinical Trials Clinical Trials 52

XTalks

OCTOBER 20, 2021

In this episode, the editorial team talks about Moderna’s unwillingness to share its COVID-19 vaccine formula with other countries, namely low- and middle-income countries that continue to face issues accessing COVID-19 vaccines. The team discusses these issues in the face of global vaccine inequities. Singer Mary J.

Life Science 52

Life Science Vaccination Vaccine Clinical Trials 52

XTalks

JULY 25, 2023

Emergent BioSolutions, a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland, has achieved a significant milestone with the approval of its Cyfendus (Anthrax Vaccine Adsorbed, Adjuvanted) vaccine by the US Food and Drug Administration (FDA). How Does Cyfendus Work? mL for intramuscular injection.

FDA Approval 98

FDA Approval Vaccination Vaccine Antibody 98

BioSpace

OCTOBER 14, 2021

Read about TFF Pharmaceuticals and Augmenta Bioworks' dry powder COVID-19 antibody formula, the world's first gene editing clinical trial for PKU, Bayer's COVID-19 vaccine and other key developments in life sciences research.

Gene Editing 87

Gene Editing Life Science Clinical Trials Clinical Trials 87

Cloudbyz

APRIL 12, 2022

Cloudbyz , makers of digital clinical research management solutions natively built and run on the Salesforce platform is headquartered in Naperville, Illinois. Follow us on: LinkedIn | Facebook | Twitter.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

pharmaphorum

SEPTEMBER 22, 2022

Alexandre Le Vert, CEO and co-founder of Osivax, discusses the company’s breakthrough vaccine technology, oligoDOM, and how it’s driving the development of new influenza and SARS-CoV-2 vaccines that attack T-cells, providing a long-lasting effect. The technology. Antibodies cover the pathogen of the virus and neutralise it.

Vaccination 91

Vaccination Vaccine Antibody Clinical Trials 91

XTalks

NOVEMBER 4, 2022

Pfizer announced positive top-line data from a Phase III trial evaluating its respiratory syncytial virus (RSV) prefusion vaccine candidate, RSVpreF (or PF-06928316) for pregnant individuals to help protect their infants from RSV disease after birth. percent through the first 90 days of life and went down to 69.4

Vaccination 97

Vaccination Vaccine Clinical Trials Clinical Trials 97

XTalks

OCTOBER 25, 2023

The US Food and Drug Administration (FDA) has accepted AstraZeneca’s supplemental biologics license application (sBLA) for a self-administered option of its nasal influenza vaccine FluMist Quadrivalent. FluMist has been in the market since 2003 and is the only intranasal spray vaccine option against flu.

Vaccination 59

Vaccination Vaccine Sales Pharmacy 59